|
IPOs – INITIAL PUBLIC OFFERINGS IPO's are a major "movement of money" theme creating opportunities for employment seekers at all levels to participate in the growth/expansion of a company. New money equals new opportunities. Many companies seek an infusion of money from the public through registration with the Security Exchange Commission and an investment banking organization such as a stock broker. A company is promoted by a broker setting the stage for an initial opportunity for the general public to participate in a private company's anticipated growth by buying stock in the company. The infusion of money allows the company to make various improvements in their operating, marketing, research and development, or manufacturing facilities, or simply to pay down debt allowing the company to become profitable again. Most importantly, the infusion of money will allow the company to attract and retain competent employees. Being aware of IPO activity is an important part of career management. By contacting the decision-maker at the right time and the right place, the astute job seeker can minimize the competition and find, or create, the ideal position. See your consultant for details. Latest Pricings Please click on “edit” and then “find” to locate specific companies, locations, dates, etc. |
||
|
IPOs – INITIAL PUBLIC OFFERINGS |
||
| Max Re Capital Ltd. Ascot House, 28 Queen St. Hamilton HM 11, Bermuda Phone: 441-296-8800 Fax: 441-296-8811 http://www.maxre.bm Domiciled in Bermuda, Max Re Capital provides reinsurance for property/casualty and life as well as annuity markets through its Max Re subsidiary. Max Re underwrites individual and group life insurance products and offers coverage for workers' compensation, employers' liability, medical malpractice, property damage, and other casualty liability risks. The company has a joint reinsurance venture (Grand Central Re) with German banking biggie Bayerische Hypo- und Vereinsbank. Max Re Capital plans to expand in Europe (about 20% of total revenue) through Dublin-based Max Re Europe. Top Competitors American Re | Munich Re | Reinsurance Group of America |
||
| IPO Information Date went public: Aug 14, 2001 (No new pricings for September 2001) Filing Date: May 31, 2001 Proposed offer price: $16.00 to $16.50 Actual offer price: $16.00 First day open: $15.80 First day close: $15.50 Shares offered (mil.): 12.0 Offering amount (mil.): $192.0 Post-offering shares (mil.): 49.5 Underwriters: Morgan Stanley & Co. Incorporated Salomon Smith Barney Goldman, Sachs & Co. Banc of America Securities LLC Dresdner Kleinwort Wasserstein Securities LLC |
Key Numbers Company Type: Public Nasdaq: MXRE (full quote) Fiscal Year-End: December 2000 Sales (mil.): $451.3 2000 Net Inc. (mil.): $8.7 2000 Employees: 22 |
Key People Chairman, President, and CEO Robert J. Cooney Deputy Chairman Zack H. Bacon III EVP and CFO Keith S. Hynes EVP and Managing Director, Max Re Europe Limited Luc Gagnon EVP, Property and Casualty Operations W. Dave Brining |
Mykrolis Corporation |
||
| IPO Information Date went public: Aug 10, 2001 Filing Date: Mar 16, 2001 Proposed offer price: $15.00 to $17.00 Actual offer price: $15.00 First day open: $17.25 Shares offered (mil.): 7.0 Offering amount (mil.): $105.0 Post-offering shares (mil.): 40.55 Underwriters: Banc of America Securities LLC Salomon Smith Barney ABN AMRO Rothschild |
Key Numbers NYSE: MYK (full quote) Fiscal Year-End: December 2000 Sales (mil.): $355.5 1-Yr. Sales Growth: 72.3% 2000 Net Inc. (mil.): $37.4 1-Yr. Net Inc. Growth: 1,038.3% 2000 Employees: 1,130 |
Key People Chairman and CEO C. William Zadel President and COO Jean-Marc Pandraud President and CEO, Nihon Millipore MicroElectronics Hideo Takahashi VP and CFO Bertrand Loy VP, Secretary, and General Counsel Peter W. Walcott |
Omnicell, Inc. |
||
| Top Competitors AmeriSource | Cardinal Health | McKesson General Medical |
IPO Information Date went public: Aug 7, 2001 Filing Date: Mar 14, 2001 Proposed offer price: $7.00 to $9.00 Actual offer price: $7.00 First day open: $7.20 First day close: $9.62 Shares offered (mil.): 6.0 Offering amount (mil.): $42.0 Post-offering shares (mil.): 20.4 Underwriters: U.S. Bancorp Piper Jaffray CIBC World Markets SG Cowen |
Key People Chairman Randall A. Lipps President and CEO Sheldon D. Asher VP of Finance and CFO Robert Y. Newell IV VP of Engineering John D. Higham VP of Sales and Field Operations S. Michael Hanna |
Bunge Limited |
||
| IPO Information Date went public: Aug 2, 2001 Filing Date: Jul 13, 2001 Proposed offer price: $16.00 to $18.00 Actual offer price: $16.00 First day open: $16.00 First day close: $16.00 Shares offered (mil.): 17.6 Offering amount (mil.): $281.6 Post-offering shares (mil.): 81.98 Underwriters: Morgan Stanley & Co. Incorporated Credit Suisse First Boston Deutsche Banc Alex. Brown Merrill Lynch & Co. Prudential Securities, Inc. Salomon Smith Barney |
Key Numbers NYSE: BG · · #247 in Hoover's 500 Fiscal Year-End: December 2000 Sales (mil.): $9,667 1-Yr. Sales Growth: 19.7% 2000 Net Inc. (mil.): $12 2000 Employees: 18,148 |
Key People Chairman and CEO Alberto Weisser Deputy Chairman Jorge Born Jr. CFO William M. Wells President, Serrana Mario Barbosa President and CEO, Bunge Fertilizantes S.A. Maria A. Barbosa Neto |